Discovery Labs announces FDA approval of Surfaxin (lucinactant) for prevention of respiratory distress syndrome

• Book ID: 114376890
• Publisher: Elsevier Science
• Year: 2012
• Weight: 45 KB
• Volume: 2012
• Category: Article
• ISSN: 1351-4210
• DOI: 10.1016/s1351-4210(12)70134-8